125 related articles for article (PubMed ID: 19035309)
1. Albendazole-cyclodextrin complex: enhanced cytotoxicity in ovarian cancer cells.
Pourgholami MH; Wangoo KT; Morris DL
Anticancer Res; 2008; 28(5A):2775-9. PubMed ID: 19035309
[TBL] [Abstract][Full Text] [Related]
2. Complexation of albendazole with hydroxypropyl-β-cyclodextrin significantly improves its pharmacokinetic profile, cell cytotoxicity and antitumor efficacy in nude mice.
Ehteda A; Galettis P; Chu SW; Pillai K; Morris DL
Anticancer Res; 2012 Sep; 32(9):3659-66. PubMed ID: 22993303
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the complexation of albendazole with cyclodextrins for the design of new antiparasitic formulations.
Pradines B; Gallard JF; Iorga BI; Gueutin C; Loiseau PM; Ponchel G; Bouchemal K
Carbohydr Res; 2014 Oct; 398():50-5. PubMed ID: 25240182
[TBL] [Abstract][Full Text] [Related]
4. Potent inhibition of tubulin polymerisation and proliferation of paclitaxel-resistant 1A9PTX22 human ovarian cancer cells by albendazole.
Chu SW; Badar S; Morris DL; Pourgholami MH
Anticancer Res; 2009 Oct; 29(10):3791-6. PubMed ID: 19846910
[TBL] [Abstract][Full Text] [Related]
5. Correlation and in vitro studies on radioactive and nonradioactive albendazole-beta-cyclodextrin complex tablets.
Cetin EO; Ilem D; Gundogdu E; Asikoglu M; Kirilmaz L
Pharmazie; 2011 Sep; 66(9):672-6. PubMed ID: 22026122
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of albendazole:β-cyclodextrin citrate in the parenteral stage of Trichinella spiralis infection.
Codina AV; García A; Leonardi D; Vasconi MD; Di Masso RJ; Lamas MC; Hinrichsen LI
Int J Biol Macromol; 2015; 77():203-6. PubMed ID: 25790725
[TBL] [Abstract][Full Text] [Related]
7. Inclusion complex and nanoclusters of cyclodextrin to increase the solubility and efficacy of albendazole.
Pacheco PA; Rodrigues LNC; Ferreira JFS; Gomes ACP; Veríssimo CJ; Louvandini H; Costa RLD; Katiki LM
Parasitol Res; 2018 Mar; 117(3):705-712. PubMed ID: 29327323
[TBL] [Abstract][Full Text] [Related]
8. Albumin nanoparticles increase the anticancer efficacy of albendazole in ovarian cancer xenograft model.
Noorani L; Stenzel M; Liang R; Pourgholami MH; Morris DL
J Nanobiotechnology; 2015 Mar; 13():25. PubMed ID: 25890381
[TBL] [Abstract][Full Text] [Related]
9. Oral bioavailability in sheep of albendazole from a suspension and from a solution containing hydroxypropyl-beta-cyclodextrin.
Evrard B; Chiap P; DeTullio P; Ghalmi F; Piel G; Van Hees T; Crommen J; Losson B; Delattre L
J Control Release; 2002 Dec; 85(1-3):45-50. PubMed ID: 12480310
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cell proliferation, vascular endothelial growth factor and tumor growth by albendazole.
Pourgholami MH; Cai ZY; Wang L; Badar S; Links M; Morris DL
Cancer Invest; 2009 Feb; 27(2):171-7. PubMed ID: 19235589
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of albendazole in New Zealand white rabbits: oral versus intraperitoneal administration.
Cai ZY; Galettis P; Lu Y; Morris DL; Pourgholami MH
Anticancer Res; 2007; 27(1A):417-22. PubMed ID: 17352262
[TBL] [Abstract][Full Text] [Related]
12. The influence of ovarian cancer induced peritoneal carcinomatosis on the pharmacokinetics of albendazole in nude mice.
Pourgholami MH; Cai ZY; Chu SW; Galettis P; Morris DL
Anticancer Res; 2010 Feb; 30(2):423-8. PubMed ID: 20332449
[TBL] [Abstract][Full Text] [Related]
13. (13)C and (15)N solid-state NMR studies on albendazole and cyclodextrin albendazole complexes.
Ferreira MJ; García A; Leonardi D; Salomon CJ; Lamas MC; Nunes TG
Carbohydr Polym; 2015 Jun; 123():130-5. PubMed ID: 25843843
[TBL] [Abstract][Full Text] [Related]
14. Succinyl-β-cyclodextrin: Influence of the substitution degree on albendazole inclusion complexes probed by NMR.
Priotti J; García A; Leonardi D; Ferreira MJ; Lamas MC; Nunes TG
Mater Sci Eng C Mater Biol Appl; 2018 Nov; 92():694-702. PubMed ID: 30184797
[TBL] [Abstract][Full Text] [Related]
15. Acyclic Cucurbit[n]uril-Type Molecular Container Enables Systemic Delivery of Effective Doses of Albendazole for Treatment of SK-OV-3 Xenograft Tumors.
Hettiarachchi G; Samanta SK; Falcinelli S; Zhang B; Moncelet D; Isaacs L; Briken V
Mol Pharm; 2016 Mar; 13(3):809-18. PubMed ID: 26756920
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of bioavailability and anthelmintic efficacy of albendazole by solid dispersion and cyclodextrin complexation techniques.
Kalaiselvan R; Mohanta GP; Madhusudan S; Manna PK; Manavalan R
Pharmazie; 2007 Aug; 62(8):604-7. PubMed ID: 17867556
[TBL] [Abstract][Full Text] [Related]
17. Super Aqueous Solubility of Albendazole in β-Cyclodextrin for Parenteral Application in Cancer therapy.
Pillai K; Akhter J; Morris DL
J Cancer; 2017; 8(6):913-923. PubMed ID: 28529602
[TBL] [Abstract][Full Text] [Related]
18. Solid Lipid Nanoparticles of Albendazole for Enhancing Cellular Uptake and Cytotoxicity against U-87 MG Glioma Cell Lines.
Marslin G; Siram K; Liu X; Khandelwal VKM; Xiaolei S; Xiang W; Franklin G
Molecules; 2017 Nov; 22(11):. PubMed ID: 29165384
[TBL] [Abstract][Full Text] [Related]
19. Enhanced dissolution and systemic availability of albendazole formulated as solid dispersions.
Castro SG; Sanchez Bruni SF; Urbizu LP; Confalonieri A; Ceballos L; Lanusse CE; Allemandi DA; Palma SD
Pharm Dev Technol; 2013; 18(2):434-42. PubMed ID: 22670782
[TBL] [Abstract][Full Text] [Related]
20. Cyclodextrin polymers as efficient solubilizers of albendazole: complexation and physico-chemical characterization.
Joudieh S; Bon P; Martel B; Skiba M; Lahiani-Skiba M
J Nanosci Nanotechnol; 2009 Jan; 9(1):132-40. PubMed ID: 19441287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
